Contact Us for our BEST PRICE Now! +44 843 557 6440 Email Us Request a Sample
Follow RSS for latest reports on this topicBrain Cancer - Market Research and Reports
According to the American Brain Tumor Association, just over 24,000 patients will be diagnosed with a primary malignant brain tumour during 2012 in the US alone. Some 80% of primary malignant brain tumours are gliomas, a broad term which includes all tumours arising from the supportive tissue of the brain. Secondary brain cancers arise when cancer in other tissues spreads (metastasises) to the brain: an estimated 98,000—170,000 cases occur each year in the US, with metastases to the brain seen in 24-45% of all cancer patients.
There are two main types of brain cancer:
- Primary brain cancer starts in the brain.
- Metastatic brain cancer starts somewhere else in the body and moves to the brain.
Brain tumors can be benign, with no cancer cells, or malignant, with cancer cells that grow quickly.
Types of malignant tumours
Most malignant brain tumours develop from the glial tissue, which supports the brain's nerve cells. These tumours are known as gliomas.
Gliomas can be separated further, depending on the cells they developed from. For example:
- an astrocytoma develops from cells thought to provide the brain's framework
- an oligodendroglioma develops from the cells that produce the fatty covering of nerves
- an ependymoma develops from the cells that line the cavities in the brain
BioPortfolio's Easy Ordering System
- Search for the report you need from our store
- Make online payment with our easy checkout process
- Receive PDF report via email
Easy Online Payment or Pro Forma Invoice
We accept the following credit cards...
or can supply a pro-forma invoice if required.
Related Reports:
We found over 40 reports that matched your search.
Next 40 Matches >Refine your search, and find more matches, using the form above.
Brain Cancer Global Clinical Trials Review, H2, 2018 [Report Updated: 31-12-2018]
Brain Cancer Global Clinical Trials Review, H2, 2018SummaryGlobalData's clinical trial report, “Brain Cancer Global Clinical Trials Review, H2, 2018 provides an overview of Brain Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Brain Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted ...Read More >>>
Published:
2018-12-31
Published by: Global Data
Prices Starting From:
$2500
BrainCool AB (BRAIN) - Product Pipeline Analysis, 2018 Update [Report Updated: 27-12-2018]
SummaryBrainCool AB (BrainCool), a subsidiary of Dignitana AB, is a medical device company that focuses on developing, and commercializing medical cooling systems for brain cooling and pain management. The company’s products are based on the principle that applying therapeutic hypothermia contributes considerably to improved survival after an episode of cardiac arrest. The company’s product po...Read More >>>
Published:
2018-12-27
Published by: Global Data
Prices Starting From:
$750
Brain Cancer: Epidemiology Forecast to 2027 [Report Updated: 24-10-2018]
Brain Cancer: Epidemiology Forecast to 2027SummaryPrimary brain cancer is defined as a malignant neoplasm that originates in the central nervous system (CNS), which consists of the brain and spinal cord, including the brain stem. The type and severity of a brain tumor is defined by the cells from which the tumor originated, as well as by the proliferative potential of the abnormal growth. Only mal...Read More >>>
Published:
2018-10-24
Published by: Global Data
Prices Starting From:
$3995
BrainCool AB (BRAIN) - Medical Equipment - Deals and Alliances Profile [Report Updated: 23-10-2018]
SummaryBrainCool AB (BrainCool), a subsidiary of Dignitana AB, is a medical device company that focuses on developing, and commercializing medical cooling systems for brain cooling and pain management. The company’s products are based on the principle that applying therapeutic hypothermia contributes considerably to improved survival after an episode of cardiac arrest. The company’s product po...Read More >>>
Published:
2018-10-23
Published by: Global Data
Prices Starting From:
$250
Traumatic Brain Injury - Pipeline Review, H2 2018 [Report Updated: 10-07-2018]
Traumatic Brain Injury - Pipeline Review, H2 2018SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Traumatic Brain Injury - Pipeline Review, H2 2018, provides an overview of the Traumatic Brain Injury (Central Nervous System) pipeline landscape.Traumatic brain injury happens when an external mechanical force causes brain damage. Traumatic brain injury usual...Read More >>>
Published:
2018-07-10
Published by: Global Markets Direct
Prices Starting From:
$2000
Global Brain Cancer Partnering 2012 to 2018 [Report Updated: 01-03-2018]
Global Brain Cancer Partnering Terms and Agreements since 2012 report provides the reader with the following key benefits:
• In-depth understanding of deal trends since 2012
• Access to headline, upfront, milestone and royalty data
• Comprehensive access to multiple deals entered into by the world’s biopharma companies since 2012
• Insight into key deal terms included in coRead More >>>
Published:
2018-03-01
Published by: Current Partnering
Prices Starting From:
$1495
Brain Hemorrhage - Pipeline Insight, 2018 [Report Updated: 14-02-2018]
Brain Hemorrhage - Pipeline Insight, 2018” report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Brain Hemorrhage development. The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental st...Read More >>>
Published:
2018-02-14
Published by: Delve Insight
Prices Starting From:
$1250
Brain Ischemia - Pipeline Insight, 2018 [Report Updated: 14-02-2018]
Brain Ischemia - Pipeline Insight, 2018” report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Brain Ischemia development. The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage,...Read More >>>
Published:
2018-02-14
Published by: Delve Insight
Prices Starting From:
$1250
Brain Metastasis - Pipeline Insight, 2018 [Report Updated: 14-02-2018]
Brain Metastasis - Pipeline Insight, 2018” report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Brain Metastasis development. The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental st...Read More >>>
Published:
2018-02-14
Published by: Delve Insight
Prices Starting From:
$1500
Traumatic Brain Injury(TBI) - Pipeline Insights, 2018 [Report Updated: 14-02-2018]
Traumatic Brain Injury(TBI) - Pipeline Insight, 2018 - Pipeline Insight, 2018” report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Traumatic Brain Injury(TBI) - Pipeline Insight, 2018 development. The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data f...Read More >>>
Published:
2018-02-14
Published by: Delve Insight
Prices Starting From:
$2000
Brain Hemorrhage -Epidemiology Forecast to 2027 [Report Updated: 14-02-2018]
DelveInsight's Brain Hemorrhage - Epidemiology Forecast, 2027” report provides a comprehensive analysis of the Brain Hemorrhage epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2027. Markets Covered• United States• EU5 (Germany, France, Italy, Spain, and the United Kingdom)• Japan Study Period: 2016-2027 Brain Hemorrhage Epidem...Read More >>>
Published:
2018-02-14
Published by: Delve Insight
Prices Starting From:
$3250
Traumatic Brain Injury -Epidemiology Forecast to 2027 [Report Updated: 14-02-2018]
DelveInsight's Traumatic Brain Injury - Epidemiology Forecast, 2027” report provides a comprehensive analysis of the Traumatic Brain Injury epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2027. Markets Covered• United States• EU5 (Germany, France, Italy, Spain, and the United Kingdom)• Japan Study Period: 2016-2027 Traumatic Br...Read More >>>
Published:
2018-02-14
Published by: Delve Insight
Prices Starting From:
$3250
Global Brain Tumor Therapeutics Market - Segmented by Type of Cancer and Therapeutics - Growth, Trends and Forecasts (2018 - 2023) [Report Updated: 08-02-2018]
The global brain tumor therapeutics market has been estimated to reach USD 2.74 billion in 2023. The market is expected to register a CAGR of 11% during the forecast period 2018 to 2023. North America dominates the market due to the increasing technological advancements. Developed healthcare infrastructure, greater per capita healthcare spending, and comparatively higher awareness regarding advanc...Read More >>>
Published:
2018-02-08
Published by: Mordor Intelligence LLC
Prices Starting From:
$4250
Global Brain Cancer Partnering 2010 to 2017 [Report Updated: 01-11-2017]
Global Brain Cancer Partnering Terms and Agreements since 2010 report provides the reader with the following key benefits:
• In-depth understanding of deal trends since 2010
• Access to headline, upfront, milestone and royalty data
• Comprehensive access to multiple deals entered into by the world’s biopharma companies since 2010
• Insight into key deal terms included in coRead More >>>
Published:
2017-11-01
Published by: Current Partnering
Prices Starting From:
$1495
Brain Hemorrhage -Epidemiology Forecast to 2025 [Report Updated: 10-10-2017]
DelveInsight “Brain Hemorrhage - Epidemiology Forecast To 2025” provides an overview of the epidemiology trends of Brain Hemorrhage in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted data of Brain Hemorrhage prevalent or incident cases segmented by age, sex and subpopulations. The Report also discusses the preva...Read More >>>
Published:
2017-10-10
Published by: Delve Insight
Prices Starting From:
$2750
Traumatic Brain Injury -Epidemiology Forecast to 2025 [Report Updated: 10-10-2017]
DelveInsight “Traumatic Brain Injury - Epidemiology Forecast To 2025” provides an overview of the epidemiology trends of Traumatic Brain Injury in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted data of Traumatic Brain Injury prevalent or incident cases segmented by age, sex and subpopulations. The Report also d...Read More >>>
Published:
2017-10-10
Published by: Delve Insight
Prices Starting From:
$2750
Oncology Drugs Market Global Report 2017 Including: Lung Cancer, Pancreatic Cancer, Breast Cancer, Prostate Cancer, Ovarian Cancer, Colorectal Cancer, Gastric Cancer, Non-Small Cell Lung Cancer , Kidney Cancer, Brain Tumor, Thyroid Cancer, Skin Cancer, Bladder Cancer, Cervical Cancer, Blood Cancer, Others (Kaposi Sarcoma, Aids-Related Lymphoma, Anal Cancer, Bone Cancer, Retinoblastoma, Testicula [Report Updated: 17-07-2017]
Oncology Drugs market covers drugs that are used in the treatment of a wide range of cancer, sarcoma, and tumor. Some of the bestselling oncology drugs in 2016 include Avastin, Herceptin, Revlimid, MabThera/Rituxan, Gleevac/Glivec, Alimta, Zytiga, Tasigna, Sandostatin, and Afinitor.
The global oncology drugs market was estimated to be around 8 billion as of 2016. The oncology drugs market market made up around 11% Read More >>>
Published:
2017-07-17
Published by: The Business Research Company
Prices Starting From:
$4000
Traumatic Brain Injury - Pipeline Review, H2 2017 [Report Updated: 11-07-2017]
Traumatic Brain Injury - Pipeline Review, H2 2017SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Traumatic Brain Injury - Pipeline Review, H2 2017, provides an overview of the Traumatic Brain Injury (Central Nervous System) pipeline landscape.Traumatic brain injury happens when an external mechanical force causes brain damage. Traumatic brain injury usual...Read More >>>
Published:
2017-07-11
Published by: Global Markets Direct
Prices Starting From:
$2000
Brain Hemorrhage - Pipeline Insight, 2017 [Report Updated: 10-07-2017]
DelveInsight’s, “ Brain Hemorrhage -Pipeline Insights, 2017”, report provides comprehensive insights about pipeline drugs across this Brain Hemorrhage. The key objective of the report is to establish the understanding for all the pipeline drugs that are undergoing research across Brain Hemorrhage. This report provides information on the therapeutic development for Brain Hemorrhage, dealing w...Read More >>>
Published:
2017-07-10
Published by: Delve Insight
Prices Starting From:
$1250
Brain Ischemia - Pipeline Insight, 2017 [Report Updated: 10-07-2017]
DelveInsight’s, “ Brain Ischemia -Pipeline Insights, 2017”, report provides comprehensive insights about pipeline drugs across this Brain Ischemia. The key objective of the report is to establish the understanding for all the pipeline drugs that are undergoing research across Brain Ischemia. This report provides information on the therapeutic development for Brain Ischemia, dealing with all ...Read More >>>
Published:
2017-07-10
Published by: Delve Insight
Prices Starting From:
$1250
Brain Metastasis - Pipeline Insight, 2017 [Report Updated: 10-07-2017]
DelveInsight’s, “ Brain Metastasis -Pipeline Insights, 2017”, report provides comprehensive insights about pipeline drugs across this Brain Metastasis. The key objective of the report is to establish the understanding for all the pipeline drugs that are undergoing research across Brain Metastasis. This report provides information on the therapeutic development for Brain Metastasis, dealing w...Read More >>>
Published:
2017-07-10
Published by: Delve Insight
Prices Starting From:
$1500
Traumatic Brain Injury(TBI) - Pipeline Insights, 2017 [Report Updated: 10-07-2017]
DelveInsight’s, “Traumatic Brain Injury-Pipeline Insights, 2017”, report provides comprehensive insights about pipeline drugs across this indication. Key objective of the report is to establish the understanding for all the pipeline drugs that fall under Traumatic Brain Injury. This report provides information on the therapeutic development based on the Traumatic Brain Injury dealing with al...Read More >>>
Published:
2017-07-10
Published by: Delve Insight
Prices Starting From:
$2000
Brain Cancer Global Clinical Trials Review, H1, 2017 [Report Updated: 31-05-2017]
Brain Cancer Global Clinical Trials Review, H1, 2017SummaryGlobalData's clinical trial report, “Brain Cancer Global Clinical Trials Review, H1, 2017 provides an overview of Brain Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Brain Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted ...Read More >>>
Published:
2017-05-31
Published by: Global Data
Prices Starting From:
$2500
Brain Ischemia - Pipeline Review, H1 2017 [Report Updated: 23-05-2017]
Brain Ischemia - Pipeline Review, H1 2017SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Brain Ischemia - Pipeline Review, H1 2017, provides an overview of the Brain Ischemia (Central Nervous System) pipeline landscape.Brain ischemia is a stroke is when the blood supply to any part of the brain is interrupted, resulting in tissue death and loss of brain f...Read More >>>
Published:
2017-05-23
Published by: Global Markets Direct
Prices Starting From:
$2000
Cancer Immunotherapy Market by Technology (Monoclonal Antibodies, Cytokines & Immunomodulators, and Others), by Application (Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Prostate Cancer, Head & Neck Cancer, and Others) by End User (Hospitals, Cancer Research Centers, and Clinics) - Global Opportunity Analysis and Industry Forecast, 2014-2022 [Report Updated: 18-05-2017]
CHAPTER 1 INTRODUCTION1.1. REPORT DESCRIPTION1.2. KEY BENEFITS1.3. KEY MARKET SEGMENT1.4. RESEARCH METHODOLOGY1.4.1. Secondary research1.4.2. Primary research1.5. ANALYST TOOLS AND MODELSCHAPTER 2 EXECUTIVE SUMMARY2.1. KEY FINDINGS OF THE STUDY2.2. CXO PERSPECTIVECHAPTER 3 MARKET OVERVIEW3.1. MARKET DEFINITION AND SCOPE3.2. KEY FINDINGS3.2.1. Top investment pockets3.2.2. Top winning strategies3.3....Read More >>>
Published:
2017-05-18
Published by: Allied Market Research
Prices Starting From:
$5370
Brain Monitoring Devices Global Market - Forecast to 2023 [Report Updated: 10-04-2017]
Brain monitoring is a technology including the application of different devices to image or monitor the structure, function or pharmacology of the brain. Brain monitoring techniques are segmented into structural imaging and functional imaging where structural imaging includes the diagnosis of the nervous system in a larger scale for the disorders like tumor, injury by techniques like CT and MRI. F...Read More >>>
Published:
2017-04-10
Published by: IQ4I
Prices Starting From:
$4950
Traumatic Brain Injury - Pipeline Review, H1 2017 [Report Updated: 28-02-2017]
Traumatic Brain Injury - Pipeline Review, H1 2017SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Traumatic Brain Injury - Pipeline Review, H1 2017, provides an overview of the Traumatic Brain Injury (Central Nervous System) pipeline landscape.Traumatic brain injury happens when an external mechanical force causes brain damage. Traumatic brain injury usual...Read More >>>
Published:
2017-02-28
Published by: Global Markets Direct
Prices Starting From:
$2000
Cancer Biomarkers Market by Profiling Technology (Omic Technologies, Imaging Technologies, Immunoassays, and Cytogenetics Based Tests), Biomolecules (Genetic Biomarkers, Protein Biomarkers, and Glycoprotein Biomarkers), Cancer Type (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Stomach Cancer, and Other Cancers), Application (Diagnostics, Drug Discovery and Development, Prognosti [Report Updated: 01-12-2016]
Cancer biomarkers are biomolecules that specifies the existence of cancer or cancerous cells in the body. These are generally molecules that are released due to the presence of a tumor or a particular indication in the body to the presence of cancer. These molecules are densely distributed in tissues, urine, serum, blood, and other body fluids. Their expression levels serve as the basis or indicat...Read More >>>
Published:
2016-12-01
Published by: Allied Market Research
Prices Starting From:
$5370
Brain Hemorrhage - Pipeline Review, H2 2016
Brain Hemorrhage - Pipeline Review, H2 2016SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Brain Hemorrhage - Pipeline Review, H2 2016, provides an overview of the Brain Hemorrhage (Central Nervous System) pipeline landscape.Brain hemorrhage is a type of stroke. It is caused by the bursting of an artery in the brain that leads to localized bleeding in the...Read More >>>
Published:
2016-11-30
Published by: Global Markets Direct
Prices Starting From:
$2000
Brain Edema - Pipeline Review, H2 2016
Brain Edema - Pipeline Review, H2 2016SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Brain Edema - Pipeline Review, H2 2016, provides an overview of the Brain Edema (Central Nervous System) pipeline landscape.Brain swelling is enlargement of the brain due to excessive fluid collection in the chambers, or ventricles, of the brain or the accumulation of fl...Read More >>>
Published:
2016-11-30
Published by: Global Markets Direct
Prices Starting From:
$2000
Global Brain Cancer Partnering 2010 to 2016
Provides understanding and access to the brain cancer partnering deals and agreements entered into by the worlds leading healthcare companies .
Read More >>>Published:
2016-11-01
Published by: Current Partnering
Prices Starting From:
$1495
Global Traumatic Brain Injury Partnering 2010 to 2016
Provides comprehensive understanding and unprecedented access to the thaumatic brain injury partnering deals and agreements entered into by the worlds leading healthcare companies.
Read More >>>Published:
2016-11-01
Published by: Current Partnering
Prices Starting From:
$1495
Brain & CNS Cancer Forecast in 19 Major Markets 2016-2026 [Report Updated: 01-05-2016]
Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Brain & CNS Cancer in 19 Major MarketsPrimary brain and central nervous system (CNS) tumours (ICD-10 codes C70-C72) are a group of primary tumours arising in the brain, meninges or central nervous system. As such, this is a cluster of conditions rather than one disease per se. There are considered to be over 120 types of brain t...Read More >>>
Published:
2016-05-01
Published by: Black Swan Analysis
Prices Starting From:
$6100
Brain Implants Market: By Type (Deep Brain Stimulator (DBS), Vagus Nerve Stimulator (VNS), and Spinal Cord Stimulator (SCS)), & By Region-Forecast (2016-2021) [Report Updated: 22-03-2016]
Brain implants, also referred as neural implants are connected directly to the brain either by placing on the brain surface i.e., over gyri and sulci, or they are attached to the cortex of brain. When brain becomes dysfunction because of various reasons such as head injuries and stroke, brain implants are used. Brain implants electrically stimulate, block, record or both record and stimulate simul...Read More >>>
Published:
2016-03-22
Published by: Industry ARC
Prices Starting From:
$5250
Cancer Immunotherapy Market: By Cancer Type (Cancer Monoclonal Antibodie, Immune Checkpoint Inhibitors, Cancer Vaccines, Non-Specific Immunotherapies & Others) & Geography-Forecast (2016-2021) [Report Updated: 26-02-2016]
Immunotherapy is also known as biologic therapy for cancer treatment. Immunotherapy is treatment which is carried out using certain parts of a person’s immune system to fight diseases such as cancer. Immunotherapy is can be done in two ways which includes either stimulating person’s own immune system to work harder or smarter to attack cancer cells or injecting immune system components, such a...Read More >>>
Published:
2016-02-26
Published by: Industry ARC
Prices Starting From:
$5250
Alpha-fetoprotein (AFP) Testing Market: By Cancer Type (Liver Cancer, Testes Cancer, Ovarian Cancer, Biliary Tract Cancer, Stomach Cancer, Pancreatic Cancer, Others (Cirrhosis, and Hepatitis)) & Geography-Forecast (2016-2021) [Report Updated: 22-01-2016]
An alpha-fetoprotein (AFP) test is a blood test that measures the amount of AFP present in blood. It’s usually part of what’s called a triple screen or quad screen in the second trimester of pregnancy. The AFP protein found in humans is encoded by the AFP gene that is located on chromosome 4. The yolk sac and immature liver of an unborn baby produce AFP which then circulates through the fetal ...Read More >>>
Published:
2016-01-22
Published by: Industry ARC
Prices Starting From:
$5250
Brain Edema Global Clinical Trials Review, H2, 2015
Brain Edema Global Clinical Trials Review, H2, 2015SummaryGlobalData's clinical trial report, “Brain Edema Global Clinical Trials Review, H2, 2015 provides an overview of Brain Edema clinical trials scenario. This report provides top line data relating to the clinical trials on Brain Edema. Report includes an overview of trial numbers and their average enrollment in top countries conducted acro...Read More >>>
Published:
2015-12-16
Published by: Global Data
Prices Starting From:
$2500
Brain Hemorrhage Global Clinical Trials Review, H2, 2015
Brain Hemorrhage Global Clinical Trials Review, H2, 2015SummaryGlobalData's clinical trial report, “Brain Hemorrhage Global Clinical Trials Review, H2, 2015 provides an overview of Brain Hemorrhage clinical trials scenario. This report provides top line data relating to the clinical trials on Brain Hemorrhage. Report includes an overview of trial numbers and their average enrollment in top coun...Read More >>>
Published:
2015-12-04
Published by: Global Data
Prices Starting From:
$2500
EpiCast Report: Brain Cancer - Epidemiology Forecast to 2024
EpiCast Report: Brain Cancer - Epidemiology Forecast to 2024SummaryPrimary brain cancer is defined as a malignant neoplasm that originates in the central nervous system (CNS), which consists of the brain and spinal cord, including the brain stem (NCI, 2015). The American Brain Tumor Association (ABTA) reports that there are over 120 different types of malignant and benign brain tumors, (ABTA, 2014...Read More >>>
Published:
2015-12-01
Published by: Global Data
Prices Starting From:
$3995
Cancer Diagnostics Market by Technology (ELISA, ELFA, PCR, NGS, Immunohistochemistry, Microarray, Imaging (MRI, CT, PET, Ultrasound, Mammography), Biopsy), Application (Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma) - Forecast to 2020
According to the CDC, cancer is the second leading cause of mortality, causing ~584,881 deaths worldwide in 2013. Early diagnosis is the key to prevent the rising number of cancer-related deaths. The global cancer diagnostics market is witnessing a rapid transformation owing to several technological advancements in diagnostic platforms such as next-generation sequencing, DNA microarrays, and polym...Read More >>>
Published:
2015-06-10
Published by: MarketsandMarkets
Prices Starting From:
$5650
Additional Searches
You may also like to search separately for: Brain Cancer